180 Life Sciences Corp.
(ATNF)
undefined
undefined%
At close: undefined
1.90
-1.55%
After-hours Dec 13, 2024, 07:44 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -19.94M | -38.73M | -20.32M | -10.88M | -25.39M | -14.50M | 123.76K |
| Depreciation & Amortization | 105.67K | 109.00K | 109.95K | 125.33K | 72.24K | 23.08K | - |
| Stock-Based Compensation | 2.28M | 2.97M | 5.00M | 1.12M | 13.30M | 4.60M | - |
| Other Working Capital | -300.51K | 1.51M | -3.08M | 105.35K | 140.99K | -117.52K | 53.56K |
| Other Non-Cash Items | 8.99M | 22.08M | 6.82M | 3.46M | 5.68M | 6.07M | -567.56K |
| Deferred Income Tax | -2.35M | -942.75K | -24.80K | -20.43K | -9.50K | - | - |
| Change in Working Capital | -14.10K | 2.72M | -8.81M | 2.33M | 3.04M | -117.52K | -53.56K |
| Operating Cash Flow | -10.92M | -12.13M | -19.37M | -3.87M | -3.32M | -3.92M | -497.36K |
| Capital Expenditures | 3.00 | - | - | - | -144.40K | -30.83K | - |
| Acquisitions | - | - | - | 3.01M | 86.08K | - | - |
| Purchase of Investments | - | - | - | - | - | - | - |
| Sales Maturities Of Investments | - | - | - | 10.28M | - | - | - |
| Other Investing Acitivies | - | - | - | 1.20M | -649.83K | -60.00K | -115.92M |
| Investing Cash Flow | - | - | - | 14.49M | -708.15K | -90.83K | -115.92M |
| Debt Repayment | -288.07K | -530.14K | 800.85K | 319.43K | 2.69M | - | - |
| Common Stock Repurchased | - | -1.01M | - | -9.01M | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - |
| Other Financial Acitivies | 196.47K | 11.40M | -2.06M | -119.36K | 1.26M | 4.77M | 116.78M |
| Financial Cash Flow | 5.91M | 10.87M | 25.41M | -8.73M | 3.94M | 4.77M | 116.78M |
| Net Cash Flow | -4.99M | -1.25M | 6.12M | 2.03M | -483.82K | -157.51K | 361.14K |
| Free Cash Flow | -10.92M | -12.13M | -19.37M | -3.87M | -3.46M | -3.95M | -497.36K |